A new treatment for prostate cancer developed and trialled in London has been licensed for use.
Enzalutamide was developed by researchers at the Royal Marsden and University College London hospitals.
The one a day pill checks the spread of the cancer.
Reseachers say the most exciting aspect of this new drug is that is has very few side effects- unlike many cancer treatements.
More top news
Reverend Simon Harvey from Islington lost his wife Jennifer to a sudden illness nine weeks ago.
Drivers will be forced to charge reasonable fares under plans to ensure tourists are not targeted by drivers trying to take advantage.
Robbie is Britain's first official bionic hound, after having his back legs strengthened with a state-of-the-art exoskeleton.